Base editors

| CRISPR Medicine | This is an overview of articles on base editors

Sign-up to weekly Newsletter here.

CMN Weekly (14 January 2022) - Your Weekly CRISPR...

Jan. 14, 2022

Some of the best links we picked up around the internet

CMN Weekly (7 January 2022) - Your Weekly CRISPR...

Jan. 7, 2022

Some of the best links we picked up around the internet

CRISPR Medicine in 2021 – What a Phenomenal Year...

Dec. 28, 2021

In 2021, we've seen positive clinical data for the first ever in vivo CRISPR medicines, base editors are heading for the clinic, and CRISPR therapies...

Disease Roundup: Sickle Cell Disease and CRISPR

Nov. 24, 2021

This up-to-date roundup presents the 7 clinical-stage gene-editing approaches to sickle cell disease, which affects millions of people worldwide and...

Building Better Base Editors: Split-Engineered DNA...

Nov. 15, 2021

At a time where base-editing technology is set to enter the clinic, researchers from Rahul Kohli’s lab at the University of Pennsylvania have made a...

BEAM-101: IND Approval for First Ever Base-Edited...

Nov. 10, 2021

On Monday, Beam Therapeutics announced that the U.S. FDA had cleared BEAM-101 for clinical evaluation as a treatment for sickle cell disease. BEAM-101...

Interview Roundup: Base Editing To Correct Rare...

Oct. 27, 2021

Base editors are derived from CRISPR-Cas technology and have the potential to cure many genetic diseases by precisely correcting single pathogenic...

First In Vivo Prime Editing Study Corrects...

Oct. 25, 2021

A recent proof-of-concept study has brought prime editing one step closer to clinical trials. Dr. Dong Hyun Jo explains how he and his colleagues...